Human Longevity, Inc. Hires Former Ancestry Executive, Scott Sorensen, As New Chief Technology Officer

INDUSTRY LEADER BRINGS 25 YEARS OF EXPERTISE IN SOFTWARE PRODUCTS AND SERVICES TO HELP HLI SCALE BUSINESS SAN DIEGO, March 19, 2018 /PRNewswire/ — Human Longevity, Inc. (HLI) – the genomics-powered health intelligence company – announced today that Scott Sorensen is joining the leadership team as Chief Technology Officer, reporting to J. Craig Venter, Ph.D., Co-Founder, Chairman and CEO. Sorensen joins... Read more

Luna DNA Expands Leadership and Advisory Board, Adding New Pedigree From Illumina

Three industry leaders join company ranks to drive genomic discovery SAN DIEGO, March 19, 2018 /PRNewswire/ — 9:30 a.m. PT — Luna DNA, the first community owned genomic and medical research database, today announced the addition of three new members to its leadership team. The key hires in the VP of marketing and VP of business strategy and operation... Read more

Horizon Discovery and Genewell Biotechnology enter into partnership for distribution of diagnostic reference standards for the Chinese market

Location: Cambridge 16/03/2018 Partnership immediately provides Horizon with deeper access to Chinese diagnostic assay manufacturers and potential OEM agreements as part of stated global leadership strategy Genewell to pursue CFDA approval of Horizon reference standards for broad distribution into Chinese clinical laboratory market Cambridge, UK, and Shenzhen, China, 16 March 2018: Horizon Discovery Group plc... Read more

RedShiftBio Announces Collaboration Trial Completion

https://redshiftbio.com/wp-content/uploads/2018/03/RedShiftBio-collaboration-press-release-March-2018.pdf   Academic and industrial collaborators provide validation of new bioanalytical platform as product launch approaches; new website unveiled. Burlington, MA 14 March 2018​. RedShift BioAnalytics, Inc. (RedShiftBio), a provider of analytical instrumentation for the characterization of protein therapeutics, is pleased to announce the completion of Phase II of the company’s collaborative trials. Conducted alongside... Read more

Bio-Techne Launches MimEX™ GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract

MINNEAPOLIS, March 14, 2018 /PRNewswire/ — Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug discovery, and disease modeling. These more complex models provide a tremendous benefit over cell line- and primary... Read more

Biomax goes brain science

FOR IMMEDIATE RELEASE: 14 March 2018 Dr. Markus Butz-Ostendorf Biomax Informatics AG Tel: +49 89 895574-0 Email: markus.butz-ostendorf@biomax.com Biomax Informatics announces pre-launch of its NeuroXM™ Brain Science Suite Planegg, Germany — Biomax Informatics AG, a leading bioinformatics company with 20 years in the market, makes an important step toward new markets today. With competence in... Read more

Food Allergen Screening Method by SCIEX Receives Official Method Classification from the AOAC INTERNATIONAL

Improved mass spec method nears industrial use, promoting a possible shift in global food allergen testing March 13, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced that its highly sensitive method for analyzing food allergens has received the First Action Official Method (FAOM) classification from AOAC INTERNATIONAL’s Official Methods... Read more

Precipio Settles Lawsuit With Crede Capital

COMPLETES RESTRUCTURING OF CLOSE TO 95% TRANSGENOMIC LIABILITIES NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC, restructuring the final substantial liability of legacy payables inherited as part of the merger with Transgenomic in June 2017. These... Read more

Edico Genome Announces Flagship Global Distribution Partnership Program

SAN DIEGO — March 13, 2018 – Edico Genome, the leading secondary analysis solution provider for next-generation sequencing (NGS), today unveiled its DRAGENTM Global Distribution Partner Network, a new program broadening access to its DRAGEN Bio-IT Platform to markets around the world. The Global Distribution Partner Network will provide new and existing DRAGEN customers with regionally focused... Read more